Rosalind Advisors Group Affirms 9.9% Stake in Delcath Systems, Capped by Ownership Blockers
Summary
Rosalind Advisors and its affiliates, including two board members, updated their beneficial ownership in Delcath Systems, confirming a 9.9% stake subject to ownership blockers.
Key Events
-
Significant Beneficial Ownership
Rosalind Advisors, Inc. and its affiliated funds, along with Steven Salamon and Gil Aharon, collectively report beneficial ownership of 9.9% of Delcath Systems' common stock as of December 31, 2025.
-
Ownership Blockers in Place
The reported stake is subject to conversion and exercise blockers, limiting beneficial ownership to 9.99% for preferred stock and 4.99% for warrants, preventing full conversion/exercise of their holdings.
-
Board Representation
Steven Salamon and Gilad Aharon, associated with the Rosalind group, were elected as independent directors in May 2020, highlighting the group's ongoing influence.
Analysis
This Schedule 13D/A filing updates the beneficial ownership of Rosalind Advisors, Inc. and its affiliated funds, along with Steven Salamon and Gil Aharon, in Delcath Systems. The group collectively reports a 9.9% stake in the company as of December 31, 2025. This significant ownership is subject to conversion and exercise blockers, limiting their beneficial ownership to 9.99% for preferred stock and 4.99% for warrants. The filing also notes that Steven Salamon and Gilad Aharon, both associated with Rosalind Advisors, were elected as independent directors in May 2020, indicating an ongoing influential position within the company.
At the time of this filing, DCTH was trading at $10.11 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $357M. The 52-week trading range was $8.12 to $18.23. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.